Pre-existing low-avidity neutralizing maternal measles antibodies do not interfere with the development of high concentrations of high-avidity measles antibodies in children immunized at age 12 months.
An investigational pneumococcal protein-based vaccine co-administered with PCV13 was well-tolerated and immunogenic but did not show incremental efficacy in preventing AOM or acute lower respiratory tract infection in children.
The Norwalk GI.1 virus Lot 001-09NV may be a useful challenge strain for future norovirus vaccine development.
The world’s first Ebola vaccine has been approved by the European Commission, and it was quickly prequalified by the World Health Organization.
About one in three individuals with atherosclerotic cardiovascular disease (ASCVD) did not receive an influenza vaccination in the past year.
Assuming the current rates of medical exemptions persist, the overall exemption rate in California schools is expected to stabilize at 1.87% by 2027.
Tecovirimat was safe and well-tolerated in a laboratorian who was inadvertently exposed to replication-competent vaccinia virus.
The rate of religious exemptions for vaccination among kindergartners is associated with the availability of personal belief exemptions.
Among sexually active adolescent girls, oral human papillomavirus infection is not uncommon, but is significantly lower among those who have received an HPV vaccination,
Researchers highlighted the need for rapid investigations of vaccine safety concerns to use robust epidemiologic methods to maintain public and professional confidence in vaccination programs.
